ALaCART-B: Acute Leukemia and Chimeric Antigen Receptor-T Cell Therapy for B-lymphoblastic Leukemia.

Clinical trial NCT05038696 · UNKNOWN

Trial details

NCT number: NCT05038696
Sponsor: National University Hospital, Singapore
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Lymphoblastic Leukemia, Acute, Childhood Lymphoblastic Leukemia Lymphoblastic Leukemia, Acute Adult Lymphoblastic Leukemia in Children CAR CAR T-Cell-Related Encephalopathy Syndrome

Start date: 2021-04-28
Primary completion: 2026-05-01
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.